Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|February 7, 2013
Synthesis of cyclic pyranopterin monophosphate, a biosynthetic intermediate in the molybdenum cofactor pathwayKeith Clinch, Derek K Watt, Rachel A Dixon, et al.
Molecular Immunology|December 5, 2018
The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse modelsMasha Fridkis-Hareli, Michael Storek, Eran Or, et al.
Frontiers in Immunology|July 5, 2022
Development and Optimization of Bifunctional Fusion Proteins to Locally Modulate Complement Activation in Diseased TissueKelly C Fahnoe, Fei Liu, Jennifer G Morgan, et al.
Eclinicalmedicine|August 2, 2024
Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part BAlexander Röth, Sigbjørn Berentsen, Wilma Barcellini, et al.
Blood|June 10, 2022
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trialAlexander Röth, Sigbjørn Berentsen, Wilma Barcellini, et al.
Blood Advances|July 5, 2024
Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2, and PRN473 reduces venous thrombosis formation in miceChristopher W Smith, Joana Campos, Helena C Brown, et al.
Pageof 2